Identification of Genetic Drivers for Esophageal Cancer Creates New Opportunity for Screening, Treatment
Mass General Cancer Center investigators found that nine percent of esophageal adenocarcinoma patients harbor mutations in cancer-predisposing genes, shedding light on the causes of progression to the disease and new possibilities for screening and treatment.